Growth Metrics

Scholar Rock Holding (SRRK) Accumulated Depreciation & Amortization (2017 - 2025)

Scholar Rock Holding's quarterly Accumulated Depreciation & Amortization came in at $14.9 million in Q4 2025, up 12.54% year-on-year from $13.2 million in Q4 2024, and up 12.54% quarter-over-quarter from $13.2 million in Q4 2024.

Scholar Rock Holding has reported Accumulated Depreciation & Amortization for 9 years, with the latest figure at $14.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 12.54% year-over-year to $14.9 million; the trailing twelve-month figure through Dec 2025 stood at $14.9 million (up 12.54% YoY), and the FY2025 full-year result was $14.9 million, up 12.54% from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 stood at $14.9 million, up from $13.2 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $14.9 million in Q4 2025, with the low at $7.3 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $11.4 million, with a median of $11.3 million recorded in 2023.
  • Year-over-year, Accumulated Depreciation & Amortization surged 50.05% in 2021 and climbed 10.7% in 2023.
  • Tracing SRRK's Accumulated Depreciation & Amortization over 5 years: stood at $7.3 million in 2021, then soared by 40.32% to $10.2 million in 2022, then rose by 10.7% to $11.3 million in 2023, then grew by 16.7% to $13.2 million in 2024, then climbed by 12.54% to $14.9 million in 2025.
  • The last three Accumulated Depreciation & Amortization figures came in at $14.9 million (Q4 2025), $13.2 million (Q4 2024), and $11.3 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 14.88 Mn
Dec 31, 2025 14.88 Mn
Dec 31, 2024 13.22 Mn
Dec 31, 2024 13.22 Mn
Dec 31, 2023 11.33 Mn
Dec 31, 2023 11.33 Mn
Dec 31, 2022 10.23 Mn
Dec 31, 2022 10.23 Mn
Dec 31, 2021 7.29 Mn
Dec 31, 2021 7.29 Mn
Dec 31, 2020 4.86 Mn
Dec 31, 2020 4.86 Mn
Dec 31, 2019 3.56 Mn
Dec 31, 2019 3.56 Mn
Dec 31, 2018 2.36 Mn
Dec 31, 2018 2.36 Mn
Sep 30, 2018 2.12 Mn
Sep 30, 2018 2.12 Mn
Jun 30, 2018 1.91 Mn
Jun 30, 2018 1.91 Mn
Dec 31, 2017 1.55 Mn
Dec 31, 2017 1.55 Mn